Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
复制标题
DOI:
10.1371/journal.pone.0028951
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Meese E
中科院分区:
文献类型:
--
作者:
Schmitt J;Keller A;Nourkami-Tutdibi N;Heisel S;Habel N;Leidinger P;Ludwig N;Gessler M;Graf N;Berthold F;Lenhof HP;Meese E
Several studies report autoantibody signatures in cancer. The majority of these studies analyzed adult tumors and compared the seroreactivity pattern of tumor patients with the pattern in healthy controls. Here, we compared the autoimmune response in patients with neuroblastoma and patients with Wilms tumor representing two different childhood tumors. We were able to differentiate untreated neuroblastoma patients from untreated Wilms tumor patients with an accuracy of 86.8%, a sensitivity of 87.0% and a specificity of 86.7%. The separation of treated neuroblastoma patients from treated Wilms tumor patients' yielded comparable results with an accuracy of 83.8%. We furthermore identified the antigens that contribute most to the differentiation between both tumor types. The analysis of these antigens revealed that neuroblastoma was considerably more immunogenic than Wilms tumor. The reported antigens have not been found to be relevant for comparative analyses between other tumors and controls. In summary, neuroblastoma appears as a highly immunogenic tumor as demonstrated by the extended number of antigens that separate this tumor from Wilms tumor.
登录
查看更多内容
影响因子:
5.8
作者:
Leidinger P;Keller A;Heisel S;Ludwig N;Rheinheimer S;Klein V;Andres C;Staratschek-Jox A;Wolf J;Stoelben E;Stephan B;Stehle I;Hamacher J;Huwer H;Lenhof HP;Meese E
通讯作者:
Meese E
影响因子:
4.8
作者:
Ludwig, Nicole;Keller, Andreas;Meese, Eckart
通讯作者:
Meese, Eckart
影响因子:
45.3
作者:
BRODEUR, GM;PRITCHARD, J;VOUTE, PA
通讯作者:
VOUTE, PA
影响因子:
6.4
作者:
Leidinger,Petra;Keller,Andreas;Meese,Eckart
通讯作者:
Meese,Eckart
影响因子:
56.9
作者:
BRODEUR, GM;SEEGER, RC;BISHOP, JM
通讯作者:
BISHOP, JM